References
- Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol 17, 207–224, 2021.
- Desai D, McPherson LA, Higgins JP, Weigel RJ. Genetic analysis of a papillary thyroid carcinoma in a patient with MEN1. Ann Surg Oncol 8, 342–346, 2001.
- Eller-Vainicher C, Chiodini I, Battista C, Viti R, Mascia ML, Massironi S, Peracchi M, D’Agruma L, Minisola S, Corbetta S, Cole DEC, Spada A, Scillitani A. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res 24, 1404–1410, 2009.
- Falchetti A. Genetics of multiple endocrine neoplasia type 1 syndrome: what’s new and what’s old. F1000Research 6, F1000 Faculty Rev–73, 2017.
- Kamilaris CDC, Stratakis CA. Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis. Front Endocrinol 10, 339, 2019.
- Kim HJ, Park JS, Kim CS, Kang ES, Cha BS, Lim SK, Kim KR, Lee HC, Ahn CW. A case of multiple endocrine neoplasia type 1 combined with papillary thyroid carcinoma. Yonsei Med J 49, 503–506, 2008.
- Kytola S, Villablanca A, Ebeling T, Nord B, Larsson C, Hoog A, Wong FK, Valimaki M, Vierimaa O, Teh BT, Salmela PI, Leisti J. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland. J Med Genet 38, 185–189, 2001.
- Liu Q, Wu L, Zheng X, Ma C, Na R, Qiu L, Liu Z, Liao L. Multiple endocrine neoplasia type 1 with ectopic parathyroid adenoma. Arch Med Sci 18, 829–832, 2022.
- Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Emmert-Buck MR, Debelenko LV, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Liotta LA, Collins FS, Chandrasekharappa SC, Spiegel AM, Burns AL. Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1). J Intern Med 243, 447–453, 1998.
- Mele C, Mencarelli M, Caputo M, Mai S, Pagano L, Aimaretti G, Scacchi M, Falchetti A, Marzullo P. Phenotypes associated with MEN1 syndrome: a focus on genotype-phenotype correlations. Front Endocrinol 11, 591501, 2020.
- Perakakis N, Flohr F, Kayser G, Thomusch O, Parsons L, Billmann F, von Dobschuetz E, Rondot S, Seufert J, Laubner K. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype. Hormones (Athens)15, 113–117, 2016.
- Pieterman CRC, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, Hermus ARMM, Rinkes IHMB, Vriens MR, Valk GD, DutchMEN1 study group. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg 255, 1171–1178, 2012.
- Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97, 2990–3011, 2012.
- Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX, Porchet N, Cordier M, Beroud C, Calender A. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Hum Mutat 20, 35–47, 2002.
- Xu JL, Dong S, Sun LL, Zhu JX, Liu J. exon. World J Clin Cases 10, 1032–1040, 2022.